column
    Base on human being, develop with the times, to improve our service level accordingly——on the necessity of a license for the oncologists
    2003, 3(3): 129-131. DOI: 10.3969/j.issn.1671-5144.2003.03.001
    Abstract PDF
    A comparative study of 18FDG-PET and CT on diagnosing mediastinal lymph nodes in non-small cell lung cancer -- an SROC-based meta-analysis for literature published between 1999 and 2002
    , ,
    2003, 3(3): 132-141. DOI: 10.3969/j.issn.1671-5144.2003.03.002
    Abstract PDF
    Analysis of articles on therapy published in 3 oncology journals during 2000-2003
    , ,
    2003, 3(3): 142-144. DOI: 10.3969/j.issn.1671-5144.2003.03.003
    Abstract PDF
    Chemoprevention of tamoxifen on benign breast disease in women
    ,
    2003, 3(3): 145-148. DOI: 10.3969/j.issn.1671-5144.2003.03.004
    Abstract PDF
    Adjuvant tamoxifen treatment in DCIS
    ,
    2003, 3(3): 149-151. DOI: 10.3969/j.issn.1671-5144.2003.03.005
    Abstract PDF
    The role of goserelin as adjuvant therapy in premenopausal patients with node-positive breast cancer
    ,
    2003, 3(3): 152-154. DOI: 10.3969/j.issn.1671-5144.2003.03.006
    Abstract PDF
    Anastrozole: a choice of adjuvant endocrine therapy for postmenopausal women with early breast cancer
    ,
    2003, 3(3): 155-159. DOI: 10.3969/j.issn.1671-5144.2003.03.007
    Abstract PDF
    Adjuvant oophorectomy and tamoxifen treatment in patients with estrogen receptor-positive and HER2/neu over expressive breast cancer
    ,
    2003, 3(3): 160-162. DOI: 10.3969/j.issn.1671-5144.2003.03.008
    Abstract PDF
    Letrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women
    ,
    2003, 3(3): 163-166. DOI: 10.3969/j.issn.1671-5144.2003.03.009
    Abstract PDF
    NCCN breast cancer practice guidelines
    , ,
    2003, 3(3): 167-192. DOI: 10.3969/j.issn.1671-5144.2003.03.010
    Abstract PDF